Introducing the new AltIndexLearn more

Johnson & Johnson (JNJ) Stock Analysis: AI Score & Alternative Data

NYSE · Drug Manufacturers · 32 members have JNJ in their Portfolio →
Price
$256.98 -0.82%
AI Score
57Hold
Earnings
N/A
Market Cap
$624B
PE Ratio
30.5
52w Range
$153 – $267
$256.98 -0.82% vs prev close
JNJ Stock Price vs. AI Score Data gathered: July 11
3M +8.4%
57/100 AI Score
Hold
Brand
29/100
Employment
50/100
User Growth
82/100
Fundamental
75/100

Today's AI read on JNJ

JNJ alt-data: revenue climbing, web traffic lagging

Is Johnson & Johnson a buy right now? The alternative data says hold. This JNJ stock analysis is built on the 25+ alternative data signals AltIndex tracks on Johnson & Johnson every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 57/100: a Hold. The stock trades at $256.98 with a $624B market cap.

The bullish side of the 90-day ledger: revenue up 9.9% YoY to $24.1B, headcount (according to LinkedIn) up 11.8% to 133K employees, and 70% of employees are positive on the business outlook. The drag: web traffic down 13.9% to 2.3M monthly visits, job postings down 10.3% to 399 open roles, and Reddit mentions down 83.3% to 1 a day. That tension is what keeps the score mid-range.

JNJ’s broader alt-data profile also covers Facebook followers (1.1M), and sentiment (85/100). Every signal links to its own page with full history, the JNJ technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on JNJ is just below.

Johnson & Johnson AI Stock Analysis

Johnson & Johnson (JNJ) is one of the largest and most diversified healthcare companies in the world. With operations spanning pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson serves millions of customers globally.

Analysis generated July 2, 2026.

Read the full JNJ deep-dive
Fundamentals, alt-data signals and the full methodology, refreshed daily.
Read full analysis

Recent Johnson & Johnson Stock Alerts

Johnson & Johnson logo Johnson & Johnson | July 7
Lloyd Doggett (member of U.S. congress) is buying shares
Johnson & Johnson logo Johnson & Johnson | June 15
Ro Khanna (member of U.S. congress) is selling shares
Johnson & Johnson logo Johnson & Johnson | June 13
Insider Alert: Wengel Kathryn E is selling shares
Johnson & Johnson logo Johnson & Johnson | June 4
Over the past few months, there has been a noticeable downward trend in Job postings.
Get JNJ alerts in real-time
The moment Reddit spikes, sentiment flips, or insiders trade.
Sign up

Johnson & Johnson Alternative Data

Alternative Data Value 3m Change Trend
Webpage Traffic 2.3M 13.9%
Job Posts 399 10.3%
LinkedIn Employees 133K 11.8%
Wikipedia Views 1K 51.0%
Employee Recommend 80 1.2%
Business Outlook 70 1.4%
Lobbying Cost $503K 0%
Sentiment 85 0%
Reddit Mentions 1 83.3%
X Mentions 16 1,500.0%
Stocktwits Mentions 99 83.3%
News Mentions 4 N/A
Stocktwits Subscribers 49K 0%
4chan Mentions 0 N/A
X Followers 242K 0%
Instagram Followers 116K 1.9%
Youtube Subscribers 75K 0%
Facebook Followers 1.1M 0%
Facebook Engagement 602 47.5%

About Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.

Johnson & Johnson logo
Price$256.98
Target Price$387.74
Volume63,420,177
Market Cap$624B
Year Range$153 – $267
Dividend Yield0%
PE Ratio30.5
Analyst Rating38% buy
IndustryDrug Manufacturers

Latest Johnson & Johnson News

View more →

Johnson & Johnson Earnings & Financial Performance

View all earnings →

Johnson & Johnson Insider Trading Activity

View all →
Wengel Kathryn E filed to sell 114,288 shares at $0.0.
Jun 11 '26
Decker Robert J filed to sell 23,682 shares at $0.0.
Feb 27 '26
Schmid Timothy filed to sell 25,447 shares at $0.0.
Feb 20 '26
Schmid Timothy filed to sell 26,769 shares at $0.0.
Feb 18 '26
Schmid Timothy filed to sell 26,769 shares at $0.0.
Feb 18 '26

Johnson & Johnson Congress Trading

View all →
Politician Filing Date Type Size
Lloyd Doggett
Jul 7, 26 Buy $8K+
Ro Khanna
Jun 11, 26 Sell $8K+
Thomas H. Kean
Apr 14, 26 Sell $8K+
John Boozman
Apr 14, 26 Sell $8K+
Ro Khanna
Apr 9, 26 Sell $8K+

Frequently Asked Questions: Johnson & Johnson (JNJ)

Johnson & Johnson has an AltIndex AI Score of 57/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.

57/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.

Currently, the price of one share of Johnson & Johnson (JNJ) stock is $256.98 with a market cap of $624B.

As of today, Johnson & Johnson’s PE (Price to Earnings) ratio is 30.5.

View the latest Johnson & Johnson insider transactions to see recent buying and selling activity by company executives and directors.

Check the Johnson & Johnson congress trading page for the latest disclosed trades by U.S. senators and representatives.

AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.

The JNJ stock price chart above shows Johnson & Johnson’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Johnson & Johnson technical analysis for RSI, moving averages, and more.

See the stocks similar to Johnson & Johnson section on this page for companies in the same industry ranked by market cap and AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.